With the emergence of legal marijuana for recreational and medical use, it’s essential to consider the benefits of having both. For example, the medical benefits of cannabis include a reduced risk of seizures for patients with Lennox-Gastaut syndrome. It also helps to reduce inflammation and disease severity.
Cannabinoids reduce inflammation and disease severity
Cannabinoids are a group of compounds that have been shown to inhibit inflammation. These compounds can affect the body’s innate inflammatory response by reducing immune signaling proteins, thereby lowering the production of inflammatory cytokines. Using cannabinoids to treat inflammatory diseases has been suggested as a potential therapeutic option. However, it is not yet clear how cannabinoids work. The research is currently limited to animal models, and the efficacy of cannabinoids in human gastrointestinal diseases has not been evaluated.
Inflammatory bowel disease (IBD) is a common chronic condition in which inflammation occurs within the gastrointestinal tract. The condition leads to abdominal pain and diarrhea. Cannabinoids are believed to have an anti-inflammatory effect and help relieve IBD symptoms. Cannabinoids in Williamstown dispensary had been tested effective in alleviating symptoms in patients with IBD.
Cannabinoids reduce the side effects of THC
Cannabinoids, also known as phytocannabinoids, are chemical compounds produced by Cannabis plants. These are responsible for the pharmacological effects that the plant possesses. They are also associated with the health benefits of the plant.
Cannabinoids have been reported to have antiemetic activity and are effective in treating nausea and vomiting caused by chemotherapy. They have also been used as a spasmolytic agent for renal colic.
The endocannabinoid system is an essential human body component in appetite, memory, and sleep. It is a crucial regulator of blood pressure. It has been shown to influence proteinuria and glomerular filtration rate.
Chronic kidney disease (CKD) is a common condition that affects more than 1.5 million people worldwide. CKD is characterized by the loss of kidney function and its associated vascular morbidity and mortality.
Cannabinoids reduce seizures in patients with refractory Lennox-Gastaut syndrome
Cannabinoids have decreased seizures in children with Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS). The FDA has authorized CBD for this ailment.
These studies were open-label, so the participants were required to meet a diagnosis of epilepsy. They were also required to have had at least two weeks of seizure control. All patients were free from epileptic spasms at the 12-month follow-up.
Support primary and clinical research into cannabis’s alleged health advantages.
Suppose the government is going to tax and regulate the production and distribution of cannabis. In that case, it should also provide funding for basic and clinical research into the purported health benefits of having medical and recreational cannabis. It would allow the public to make informed choices.
As a medical practitioner, you must know the latest information regarding the potential risks and benefits of cannabis use. However, much of the current state of knowledge about cannabis is pre-clinical and uncontrolled. Sometimes, the existing knowledge may be biased and subject to the rumor.
While there have been many positive reports of cannabis-based medicines for patients with cancer-related pain, there are still gaps in the knowledge base. There is a need for high-quality, well-controlled research to determine the safety and efficacy of the plant.
Healthcare Business Today is a leading online publication that covers the business of healthcare. Our stories are written from those who are entrenched in this field and helping to shape the future of this industry. Healthcare Business Today offers readers access to fresh developments in health, medicine, science, and technology as well as the latest in patient news, with an emphasis on how these developments affect our lives.